{
    "Trade/Device Name(s)": [
        "BD MAX CTGCTV2",
        "BD MAX System"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K182692",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151589"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OUY",
        "MKZ",
        "LSL"
    ],
    "Summary Letter Date": "January 4, 2019",
    "Summary Letter Received Date": "January 7, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3860"
    ],
    "Regulation Name(s)": [
        "Trichomonas vaginalis nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis",
        "Neisseria gonorrhoeae",
        "Trichomonas vaginalis"
    ],
    "Specimen Type(s)": [
        "Vaginal swab",
        "Endocervical swab",
        "Urine",
        "Liquid-Based Cytology (PreservCyt LBC)"
    ],
    "Specimen Container(s)": [
        "BD MAX Swab Sample Buffer Tube",
        "BD MAX Urine Sample Buffer Tube",
        "BD MAX LBC Sample Buffer Tube",
        "PreservCyt Solution vial"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX System",
        "BD Pre-warm Heater"
    ],
    "Method(s)/Technology(ies)": [
        "Automated DNA extraction",
        "Real-time PCR",
        "Hydrolysis (TaqMan) probe detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification testing (NAAT)",
        "PCR-based qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "System",
        "Cartridge",
        "Reagent",
        "Sample preparation",
        "Specimen collection device",
        "Transport medium",
        "Tube",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for BD MAX CTGCTV2 assay on BD MAX System for qualitative detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis DNA from urogenital specimens",
    "Indications for Use Summary": "Qualitative detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis DNA in vaginal swab, endocervical swab, PreservCyt LBC, and urine specimens from asymptomatic and symptomatic individuals to aid in diagnosis of urogenital infections",
    "fda_folder": "Immunology"
}